SCHEMBL1971528

SCHEMBL1971528

N[C@@H](Cc1c[nH]cn1)C(=O)c1ccc([C](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.36
CYP1A2 P05177 1/20 0.34
ALPI P09923 1/20 0.33
PKM P14618 1/20 0.33
PTGS1 P23219 1/20 0.33
XIAP P98170 1/20 0.33
SLC7A5 Q01650 1/20 0.33
KDM4E B2RXH2 3/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 1/20 0.32
MPO P05164 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
KMT2A Q03164 1/20 0.32
HIF1A Q16665 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8583698 0.88 KMT2A (0.47) PKMKDM4EMAPTLMNAMEN1
Histidine SCHEMBL28098393 0.78 CYP1A2 (0.49) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL6856397 0.78 NAMPT (0.42) CYP1A2PKMSLC7A5L3MBTL1ALDH1A1
Histidine SCHEMBL29086897 0.78 SLC7A5 (0.47) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL15513862 0.78 CYP1A2 (0.32) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL15755537 0.77 GSK3B (0.45) CYP1A2LMNAMEN1KMT2AL3MBTL1
Histidine SCHEMBL16166274 0.77 SLC7A5 (0.47) CYP1A2ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL1007041 0.77 SLC7A5 (0.63) CYP1A2ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL638657 0.77 SLC7A5 (0.63) CYP1A2ALPIPKMPTGS1XIAP
Histidine SCHEMBL28042776 0.77 SLC7A5 (0.47) CYP1A2ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177530-B1 Octapeptide having antiangiogenic activity ABBOTT LAB (US) 2011-06-22 EP disclosed
EP-2177530-A1 Octapeptide having antiangiogenic activity Abbott Laboratories (US) 2010-04-21 EP disclosed
US-20080071062-A1 TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY HAVIV FORTUNA 2008-03-20 US disclosed
US-20070167376-A1 Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity HAVIV FORTUNA 2007-07-19 US disclosed
US-7169888-B2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity ABBOTT LABORATORIES (US) 2007-01-30 US disclosed
US-7122625-B2 Hexa-, hepta-, and octapeptides having antiangiogenic activity ABBOTT LABORATORIES (US) 2006-10-17 US disclosed
US-20060194737-A1 Hepta-, octa-and nonapeptides having antiangiogenic activity HAVIV FORTUNA 2006-08-31 US disclosed
US-7067490-B2 Hepta-, Octa-and nonapeptides having antiangiogenic activity ABBOTT LABORATORIES (US) 2006-06-27 US disclosed
US-7001984-B2 Di-, tri-, and tetra-peptides having antiangiogenic activity ABBOTT LABORATORIES (US) 2006-02-21 US disclosed
EP-1232183-B1 PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY ABBOTT LAB (US) 2006-01-18 EP disclosed
US-20050215484-A1 Di-, tri-, and tetra-peptides having antiangiogenic activity HAVIV FORTUNA 2005-09-29 US disclosed
US-6753408-B1 DRUGS USED FOR THERAPY ABBVIE INC. 2004-06-22 US disclosed